4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.445 AUD -2.2% Market Closed
Market Cap: 183m AUD
Have any thoughts about
4DMedical Ltd?
Write Note

Gross Margin
4DMedical Ltd

93.7%
Current
69%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
93.7%
=
Gross Profit
3.5m
/
Revenue
3.8m

Gross Margin Across Competitors

Country AU
Market Cap 186.7m AUD
Gross Margin
94%
Country US
Market Cap 36.5B USD
Gross Margin
74%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 26.1B AUD
Gross Margin
100%
Country US
Market Cap 10.9B USD
Gross Margin
90%
Country US
Market Cap 6.4B USD
Gross Margin
67%
Country JP
Market Cap 934B JPY
Gross Margin
58%
Country US
Market Cap 5.6B USD
Gross Margin
85%
Country SE
Market Cap 53.2B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.2B CNY
Gross Margin
43%
No Stocks Found

4DMedical Ltd
Glance View

Market Cap
182.6m AUD
Industry
Health Care

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.467 AUD
Undervaluation 5%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
93.7%
=
Gross Profit
3.5m
/
Revenue
3.8m
What is the Gross Margin of 4DMedical Ltd?

Based on 4DMedical Ltd's most recent financial statements, the company has Gross Margin of 93.7%.